Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
22.21
-0.94 (-4.06%)
At close: Nov 7, 2025, 4:00 PM EST
21.80
-0.41 (-1.85%)
After-hours: Nov 7, 2025, 4:31 PM EST
Beam Therapeutics Market Cap
Beam Therapeutics has a market cap or net worth of $2.19 billion as of November 7, 2025. Its market cap has increased by 21.93% in one year.
Market Cap
2.19B
Enterprise Value
1.27B
1-Year Change
21.93%
Ranking
Category
Stock Price
$22.21
Market Cap Chart
Since February 6, 2020, Beam Therapeutics's market cap has increased from $327.97M to $2.19B, an increase of 568.34%. That is a compound annual growth rate of 39.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2025 | 2.28B | 15.75% |
| Dec 31, 2024 | 1.97B | -8.58% |
| Dec 29, 2023 | 2.16B | -19.78% |
| Dec 30, 2022 | 2.69B | -49.47% |
| Dec 31, 2021 | 5.33B | 15.54% |
| Dec 31, 2020 | 4.61B | 1,305.76% |
| Feb 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 839.37B |
| Johnson & Johnson | 450.47B |
| AbbVie | 387.13B |
| UnitedHealth Group | 291.28B |
| AstraZeneca | 260.82B |
| Novartis AG | 242.27B |
| Abbott Laboratories | 217.27B |
| Merck & Co. | 212.91B |